questionText: To ask the Secretary of State for Health and Social Care, what discussions he has had with NICE on expanding the list of weight-related comorbidities on their tirzepatide guidance to include polycystic ovarian syndrome.
answerText: The National Institute for Health and Care Excellence (NICE) has published technology appraisal guidance that recommends tirzepatide to treat obesity, alongside a reduced calorie-diet and increased physical activity, in adults with a body mass index of 35...
heading: Obesity: Drugs